Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-aminopyridine for Skin Wound Healing
NCT06333171Phase 2Recruiting
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in wound. Started Sep 2025; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
wound
Beyond the preview
Go deeper on NCT06333171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06333171.